Difficulty: Easy
Correct Answer: Ergosterol
Explanation:
Introduction / Context:
Antifungal therapy targets cellular features unique to fungi. A key difference between fungi and animals lies in the predominant sterol of the plasma membrane. This distinction underpins the selectivity of several major drug classes and is a foundational concept in medical mycology.
Given Data / Assumptions:
Concept / Approach:
Ergosterol is the signature sterol in fungal membranes. Polyene drugs such as amphotericin B bind ergosterol to form pores, and azole drugs inhibit ergosterol biosynthesis enzymes, disrupting membrane integrity. Chloroplasts occur in algae and plants, not in fungi. An undulating membrane is a surface structure seen in certain protozoa such as trypanosomes. Flagella occur in many eukaryotes but are not diagnostic for fungi. Silica frustules typify diatoms, not fungi. Therefore ergosterol is the correct differentiator in the context of clinical microbiology.
Step-by-Step Solution:
Identify the pharmacologic target unique to fungi.Relate ergosterol to mechanisms of polyenes and azoles.Exclude features that belong to other eukaryotic groups.Select “Ergosterol.”
Verification / Alternative check:
Standard pharmacology references highlight ergosterol dependent pathways as key antifungal targets, confirming its role as a major differentiator from mammalian membranes that contain cholesterol.
Why Other Options Are Wrong:
Common Pitfalls:
Confusing cell wall components (chitin and glucans) with membrane sterols. Both are helpful differentiators, but the question asks specifically for the membrane component.
Final Answer:
Ergosterol.
Discussion & Comments